Population mortality rates are considered one of the most reliable ways of measuring progress in cancer treatment and prevention. By contrast, cancer survival rates can sometimes be influenced by improvements in diagnosing tiny, early stage tumors that wouldn’t necessarily be deadly.
The results are being published in CA: A Cancer Journal for Clinicians.
This article was provided by Bloomberg News.